The impact of medical therapy for inflammatory bowel disease on pregnancy outcome

American Journal of Gastroenterology

Volumn 103, Issue 3, 2008, Pages 805-806

  Simpson, Peter W ^a   Melmed, Gil Y ^a   Dubinksy, Marla ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOPURINE;

ADVERSE OUTCOME; COMPARATIVE STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ENTERITIS; FETUS OUTCOME; HUMAN; LETTER; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

6-MERCAPTOPURINE; ABNORMALITIES, DRUG-INDUCED; CROHN DISEASE; FEMALE; FETUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 40949086863     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01612_9.x     Document Type: Letter

References (5)

1. Norgard B, Pedersen L, Christensen LA, et al. Therapeutic drug use in women with Crohn's disease and birth outcomes: A Danish nationwide cohort study. Am J Gastroenterol 2007 102 : 1406 13.
2. Jacobson JL, Jacobson SW. Methodological issues in research on developmental exposure to neurotoxic agents. Neurotoxicol Teratol 2005 27 : 395 406.
3. Norgard B, Hundborg HH, Jacobsen BA, et al. Disease activity in pregnant women with Crohn's disease and birth outcomes: A regional Danish cohort study. Am J Gastroenterol 2007 102 : 1947 54.
4. Greenland S. The effect of misclassification in the presence of covariates. Am J Epidemiol 1980 112 : 564 9.
5. Mahadevan U, Kane S. American Gastroenterological Association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006 131 : 283 311.